HBV
66
11
11
21
Key Insights
Highlights
Success Rate
75% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
10.6%
7 terminated out of 66 trials
75.0%
-11.5% vs benchmark
20%
13 trials in Phase 3/4
33%
7 of 21 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 21 completed trials
Clinical Trials (66)
Effectiveness of a Self-health Assessment Mobile Application in Young-to-midlife Adults in Hong Kong
Liver Fibrosis in Zambian HIV-HBV Co-infected Patients
Non-interventional Study to Assess the Number of People With Untreated/Unknown HBV + HDV and HCV in South-East Austria
Chronic Hepatitis B Virus Infection in Zambia
Access HBV Assays - European Union (EU) Clinical Trial Protocol -
HBV Reactivation in Immunocompromised Patients (REANT STUDY)
Changes in Bile Acids and Microbiota in Patients With Hepatitis D Treated With Bulvertide
Clinical Performance Evaluation of MagIA IVD-MD Multiplex Testing (HIV/HBV/HCV/Syphilis)
Chronic Hepatitis B Virus Clinical Epidemiology in a Representative Sample of Zambian Adults
Rapid T-cell Analysis Test in Patients With Chronic HBV and HBV/HDV Disease
Phase 1b, Open-label Study of Tune-401 to Assess Safety, PK and PD in Adults With Chronic Hepatitis B
Prospective Cohort Study on PEG-IFN-α-2b in Improving Clinical Cure Rate of Pediatric Patients With Chronic Hepatitis B
Prophylactic Entecavir for HBV Reactivation in Past HBV Infected Patients With Hematopoietic Stem Cell Transplantation
Real-world Study on Liver Cancer Risk in Chronic Hepatitis B Patients With Family History of Liver Cancer
A Real-World Study of Antiviral Therapy in Children With Chronic Hepatitis B
Study on the Treatment of Hepatitis B Virus(HBV) Infected Individuals With Peginterferon α-2b Combined With NA.
Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate for Treatment of Hepatitis B e Antigen-Positive Hepatitis B (China)
Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate for Treatment of Hepatitis B e Antigen-Negative Hepatitis B (China)
Current Situation of Health Care in Women With HBV or HCV Infection
Antiviral Therapy in Infants With HBV Infection